Searchable abstracts of presentations at key conferences in endocrinology

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0044p199 | Obesity and Metabolism | SFEBES2016

Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with PCOS

Sathyapalan Thozhukat , Javed Zeeshan , Kilpatrick Eric S , Coady Anne-Marie , Atkin Stephen L

Context: There is growing evidence that cannabinoid receptor-1 (CB-1) blockade reduces inflammation and neovascularization by decreasing vascular endothelial growth factor (VEGF) levels associated with a reduction in inflammatory markers, thereby potentially reducing cardiovascular risk.Objective: To determine the impact of CB1 antagonism by rimonabant on VEGF and inflammatory markers in obese PCOS women.Design: Randomised, open-la...

ea0059p156 | Obesity & metabolism | SFEBES2018

Randomised trial of empagliflozin versus metformin in polycystic ovary syndrome

Javed Zeeshan , Papageorgiou Maria , Kilpatrick Eric , Abbas Jehangir , Khan Amer , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Background: Empagliflozin is a sodium-glucose-cotransporter-2 that improves cardiovascular risk and weight loss in patients with type 2 diabetes. Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular risk; therefore, empagliflozin may be of benefit in PCOS.Methods: A randomised, open-label study in 40 overweight and obese women with PCOS treated with either empagliflozin 25 mg or metformin 1500mg daily for 12 weeks....

ea0038p270 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Intra-Individual correlation between flow mediated dilation and reactive hyperaemia peripheral arterial tonometry in PCOS

Ehtesham Ehtesham , Javed Zeeshan , Kilpatrick Eric S , Atkin Stephen L , Sathyapalan Thozhukat

Background: Endothelial damage is one of the early signs of cardiovascular disorders. Assessing endothelial function in women with polycystic ovary syndrome (PCOS) has shown evidence of cardiovascular disease in the absence of clinically evident disorder. Flow mediated dilation (FMD) and reactive hyperaemia peripheral arterial tonometry (RH-PAT) are the frequently used non-invasive techniques for assessing endothelial function. Both the techniques have been used to assess endo...

ea0038p444 | Thyroid | SFEBES2015

The effect of isoflavone-free soy protein supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomised double blind crossover study

Sathyapalan Thozhukat , Javed Zeeshan , Thatcher Natalie J , Rigby Alan S , Kilpatrick Eric S , Atkin Stephen L

Context: Soy phytoestrogens are suggested to have an adverse effect on thyroid function but the contribution to this by soy protein alone when free from isoflavones is unknown.Objective: The primary aim was to determine the effect of isoflavone free soy protein supplementation on thyroid function, with a secondary aim of assessing the effects on cardiovascular risk indices in patients with subclinical hypothyroidism.Design and sett...